SE348460B - - Google Patents

Info

Publication number: SE348460B
Authority: SE; Sweden

Application number

SE08943/67A

Inventor

M Wilhelm

H Keberle

J Faigle

Original Assignee

Ciba Geigy Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1963-07-09

Filing date

1964-07-08

Publication date

1972-09-04

1963-07-09 Priority claimed from CH853763A external-priority patent/CH446376A/de

1964-07-08 Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag

1972-09-04 Publication of SE348460B publication Critical patent/SE348460B/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
- C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

SE08943/67A 1963-07-09 1964-07-08 SE348460B (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CH853763A CH446376A (de)	1963-07-09	1963-07-09	Verfahren zur Herstellung neuer Aminosäuren
CH672964		1964-05-22

Publications (1)

Publication Number	Publication Date
SE348460B true SE348460B (fr)	1972-09-04

Family

ID=25700075

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
SE08945/67A SE348462B (fr)	1963-07-09	1964-07-08
SE08943/67A SE348460B (fr)	1963-07-09	1964-07-08
SE08944/67A SE348461B (fr)	1963-07-09	1964-07-08
SE8340/64A SE333151B (sv)	1963-07-09	1964-07-08	Foerfarande foer framstaellning av nya centralt haemmande verkande aminosyror och salter daerav

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
SE08945/67A SE348462B (fr)	1963-07-09	1964-07-08

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
SE08944/67A SE348461B (fr)	1963-07-09	1964-07-08
SE8340/64A SE333151B (sv)	1963-07-09	1964-07-08	Foerfarande foer framstaellning av nya centralt haemmande verkande aminosyror och salter daerav

Country Status (9)

Country	Link
US (1)	US3471548A (fr)
BE (1)	BE650258A (fr)
BR (1)	BR6460727D0 (fr)
CH (1)	CH449645A (fr)
DE (1)	DE1493536B1 (fr)
ES (1)	ES301814A1 (fr)
FR (2)	FR3692M (fr)
GB (1)	GB1017439A (fr)
SE (4)	SE348462B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3956314A (en) *	1970-07-24	1976-05-11	U.C.B., Societe Anonyme	Derivatives of 2-pyrrolidinone
US3978216A (en) *	1974-06-03	1976-08-31	Nelson Research & Development Company	Method for treating schizophrenia and method and composition for potentiating neuroleptic drugs
US3947579A (en) *	1974-06-03	1976-03-30	Nelson Research & Development Company	Method and composition for potentiating neuroleptic drugs
US4084000A (en) *	1975-07-16	1978-04-11	Nelson Research And Development Company	Method of treating schizophrenia
US4126684A (en) *	1976-02-11	1978-11-21	Ciba-Geigy Corporation	4-amino-3-p-halophenylbutyric acids and their derivatives used in the control of narcotic abuse
NL7706429A (nl) *	1977-06-10	1978-12-12	Univ Erasmus	Werkwijze voor de bereiding van een geneesmid- del met angst en angstequivalenten opheffende werking en gevormd geneesmiddel met een derge- lijke werking.
NL8006135A (nl) *	1980-11-10	1982-06-01	Univ Erasmus	Geneesmiddel met angst en angstequivalenten opheffende werking en werkwijze voor de bereiding van een dergelijk geneesmiddel.
US5006560A (en) *	1989-12-20	1991-04-09	Schering Corporation	Use of GABA-B selective agonists as anti-tussive agents
AU1182897A (en) *	1995-12-20	1997-07-14	Farmarc Nederland Bv	A process for the optical resolution of 3-(p-chlorophenyl)-glutaramide
US6001876A (en)	1996-07-24	1999-12-14	Warner-Lambert Company	Isobutylgaba and its derivatives for the treatment of pain
IL155704A0 (en)	2000-11-30	2003-11-23	Pfizer Prod Inc	Combination of gaba agonists and sorbitol dehydrogenase inhibitors
HRP20030419A2 (en)	2000-11-30	2004-08-31	Pfizer Prod Inc	Combination of gaba agonists and aldose reductase inhibitors
EP1633400A2 (fr) *	2003-05-16	2006-03-15	Pfizer Products Inc.	Combinaisons therapeutiques d'antipsychotiques atypiques avec des modulateurs de l'acide 4-aminobutanoique et/ou des medicaments anticonvulsivants
KR20110097942A (ko) *	2003-08-20	2011-08-31	제노포트 인코포레이티드	아실옥시알킬 카르바메이트 프로드러그, 합성 및 사용 방법
EP2354120A1 (fr)	2003-08-20	2011-08-10	XenoPort, Inc.	Synthèse de promédicaments a base de carbamate d'acyloxyalkyle et leurs intermédiaires
WO2005060968A1 (fr)	2003-12-11	2005-07-07	Sepracor Inc.	Combinaison d'un sedatif et d'un modulateur des neurotransmetteurs, et methodes permettant d'ameliorer la qualite du sommeil et de traiter la depression
CA2553291A1 (fr) *	2004-01-29	2005-09-09	Pfizer Products Inc.	Combinaison de modulateurs d'acide .gamma.-aminobutyrique et d'antagonistes du recepteur 5-ht1b
JP2009506069A (ja)	2005-08-26	2009-02-12	ブレインセルス，インコーポレイティド	ムスカリン性受容体調節による神経発生
EP2258359A3 (fr)	2005-08-26	2011-04-06	Braincells, Inc.	Neurogenèse par modulation des récepteurs muscariniques avec sabcomeline
US7985756B2 (en)	2005-10-21	2011-07-26	Braincells Inc.	Modulation of neurogenesis by PDE inhibition
WO2007053596A1 (fr)	2005-10-31	2007-05-10	Braincells, Inc.	Modulation de la neurogenese dont la mediation est assuree par recepteur gaba
US20100216734A1 (en)	2006-03-08	2010-08-26	Braincells, Inc.	Modulation of neurogenesis by nootropic agents
WO2007134136A2 (fr)	2006-05-09	2007-11-22	Braincells, Inc.	Neurogenèse par modulation de l'angiotensine
WO2007134077A2 (fr)	2006-05-09	2007-11-22	Braincells, Inc.	Neurogenèse induite par le récepteur 5ht
US20100197789A1 (en)	2006-08-11	2010-08-05	National University Corporation Nagoya University	Anti-obesity agent and use thereof
EP2068872A1 (fr)	2006-09-08	2009-06-17	Braincells, Inc.	Combinaisons contenant un dérivé de 4-acylaminopyridine
US20100184806A1 (en)	2006-09-19	2010-07-22	Braincells, Inc.	Modulation of neurogenesis by ppar agents
JP2010521453A (ja) *	2007-03-15	2010-06-24	サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド	新規プロドラッグ
WO2010099217A1 (fr)	2009-02-25	2010-09-02	Braincells, Inc.	Modulation de neurogenèse à l'aide de combinaisons de d-cyclosérine
WO2011113904A1 (fr)	2010-03-17	2011-09-22	INSERM (Institut National de la Santé et de la Recherche Médicale)	Médicaments pour la prévention et le traitement d'une maladie associée à la dégénérescence des cellules ganglionnaires rétiniennes
US20180208544A1 (en)	2015-07-13	2018-07-26	Piramal Enterprises Limited	An improved process for the preparation of baclofen and its intermediate
CN106187794A (zh) *	2016-07-12	2016-12-07	安徽省逸欣铭医药科技有限公司	一种巴氯芬的绿色工业化生产方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3125583A (en) *		1964-03-17		Hjnc oxchaxohxchc o oh

1963
- 1963-07-09 CH CH1468666A patent/CH449645A/de unknown
1964
- 1964-06-24 GB GB26174/64A patent/GB1017439A/en not_active Expired
- 1964-06-30 US US379365A patent/US3471548A/en not_active Expired - Lifetime
- 1964-07-03 DE DE19641493536 patent/DE1493536B1/de active Pending
- 1964-07-08 SE SE08945/67A patent/SE348462B/xx unknown
- 1964-07-08 SE SE08943/67A patent/SE348460B/xx unknown
- 1964-07-08 SE SE08944/67A patent/SE348461B/xx unknown
- 1964-07-08 SE SE8340/64A patent/SE333151B/xx unknown
- 1964-07-08 BR BR160727/64A patent/BR6460727D0/pt unknown
- 1964-07-08 BE BE650258A patent/BE650258A/xx unknown
- 1964-07-08 ES ES0301814A patent/ES301814A1/es not_active Expired
- 1964-09-15 FR FR988116A patent/FR3692M/fr not_active Expired
- 1964-09-15 FR FR988115A patent/FR3677M/fr not_active Expired

Also Published As

Publication number	Publication date
ES301814A1 (es)	1965-01-01
SE348462B (fr)	1972-09-04
GB1017439A (en)	1966-01-19
BE650258A (fr)	1965-01-08
DE1493536B1 (de)	1971-10-14
SE348461B (fr)	1972-09-04
FR3677M (fr)	1965-11-08
BR6460727D0 (pt)	1973-08-02
SE333151B (sv)	1971-03-08
US3471548A (en)	1969-10-07
FR3692M (fr)	1965-11-15
CH449645A (de)	1968-01-15

Publication	Publication Date	Title
AR142945A1 (fr)	1965-02-11
BE627012A (fr)
BE626590A (fr)
BE644350A (fr)	1964-06-15
BE627023A (fr)
BE645615A (fr)	1964-07-16
BE465565A (fr)
BE507458A (fr)
BE621232A (fr)
BE627145A (fr)
BE627151A (fr)
BE645516A (fr)	1964-09-21
BE626938A (fr)
BE623117A (fr)
BE642355A (fr)	1964-05-04
BE626358A (fr)
BE547422A (fr)
BE626826A (fr)
BE650258A (fr)	1965-01-08
BE643920A (fr)	1964-06-15
BE638260A (fr)
BE462764A (fr)
BE31062A (fr)
BE603935A (fr)
BE626915A (fr)